Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119558) titled 'A study on the efficacy and safety of SYN023 treatment for rabies patients over 18 years old' on Feb. 28.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking University First Hospital
Condition:
rabies
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-03-01
Target Sample Size: SYN023 administration group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310722
Published by HT Digital Content Services with permission from Health Daily Digest....